EUVIMEDEUVIMED entdecken
Crossref

Molecular Engineering of Pure Superoxide Radical Photogenerator for Hypoxia‐Tolerant Tumor Theranostics

Jipeng Ding, Tianyu Zhu, Fan Zheng, Feng Gao, Shengwang Zhang, Kexiang Zhang, Jinrong Zeng, Jie Dong, Wenbin Zeng iD

Small · 2024

DOI: 10.1002/smll.202405164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2024. Verfasst von Jipeng Ding und 8 weiteren Autor:innen. Beteiligte Einrichtung: Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, P. R. China. Hauptthemen laut MEDLINE: Superoxides, Photochemotherapy, Photosensitizing Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Photodynamic therapy (PDT) is a promising cancer treatment, but limited oxygen supply in tumors (hypoxia) can hinder its effectiveness. This is because traditional PDT relies on Type‐II reactions that require oxygen. Type‐I photosensitizers (PSs) offer a promising approach to overcome the limitations of tumor photodynamic therapy (PDT) in hypoxic environments. To leverage the advantages of Type‐I PDT, the design and evaluation of a series of Type‐I PSs for developing pure Type‐1 PSs, by incorporating benzene, thiophene, or bithiophene into the donor–acceptor molecular skeleton are reported. Among them, CTTI (with bithiophene) shows the best performance, generating the most superoxide radical (O 2 •− ) upon light irradiation. Importantly, CTTI exclusively produced superoxide radicals, avoiding the less effective Type‐II pathway. This efficiency is due to CTTI's energy gap and low reduction potential, which favor electron transfer to oxygen for O 2 •− generation. Finally, CTTI NPs are successfully fabricated by encapsulating CTTI into liposomes, and validated to be effective in killing tumor cells, even under hypoxic conditions, making them promising hypoxia‐tolerant tumor phototheranostic agents in both in vitro and in vivo applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SuperoxidesPhotochemotherapyPhotosensitizing AgentsHumansTheranostic NanomedicineNeoplasmsCell Line, TumorAnimalsPrecision MedicineLiposomesMiceTumor Hypoxia

Stichwörter der Autor:innen

fluorescence imaginghypoxic tumorphotodynamic therapyphotosensitizerssuperoxide radical

Substanzen

SuperoxidesPhotosensitizing AgentsLiposomes

Autor:innen und Institutionen

  • Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, P. R. China.
  • The Third Xiangya Hospital, Central South University, Changsha, 410013, P. R. China.

ORCID-Profile: Wenbin Zeng

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Foundation of Hunan Province

Zitieren

APA

Ding, J., Zhu, T., Zheng, F., Gao, F., Zhang, S., Zhang, K., Zeng, J., Dong, J., & Zeng, W. (2024). Molecular Engineering of Pure Superoxide Radical Photogenerator for Hypoxia‐Tolerant Tumor Theranostics. Small. https://doi.org/10.1002/smll.202405164

Vancouver

Ding J, Zhu T, Zheng F, Gao F, Zhang S, Zhang K, et al. Molecular Engineering of Pure Superoxide Radical Photogenerator for Hypoxia‐Tolerant Tumor Theranostics. Small. 2024. doi:10.1002/smll.202405164

BibTeX
@article{Ding2024,
  author = {Ding, Jipeng and Zhu, Tianyu and Zheng, Fan and Gao, Feng and Zhang, Shengwang and Zhang, Kexiang and Zeng, Jinrong and Dong, Jie and Zeng, Wenbin},
  title = {Molecular Engineering of Pure Superoxide Radical Photogenerator for Hypoxia‐Tolerant Tumor Theranostics},
  journal = {Small},
  year = {2024},
  doi = {10.1002/smll.202405164}
}
Kostenlos starten →